Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1366431

registered interest
date	05/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Casirivimab/imdevimab and Tixagevimab/cilgavimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 October 2021 on Coronavirus: Drugs, whether his Department plans to make Ronapreve available for the treatment and prevention of covid-19 in immunocompromised patients; what the timeline is for Medicines and Healthcare products Regulatory Agency's consideration of ADZ7442; and whether his Department plans to seek prioritisation of that appraisal.
tabling member constituency	North East Bedfordshire
tabling member printed	Richard Fuller
uin	70252
answer	answer is ministerial correction date of answer 15/11/2021 answer text <p>On 17 September, Ronapreve was made available to hospitalised patients through an interim NHS clinical policy. On 4 November 2021, the clinical policy was expanded. The clinical policy includes seronegative patients that are hospitalised for the management of acute COVID-19 infection and patients with hospital-onset COVID-19, if they are deemed to be at high risk of progression to severe COVID-19 or at risk of destabilising their condition or recovery from their procedure. This may include immunocompromised patients.</p><p>The Medicines and Healthcare products Regulatory Agency needs to ensure that products such as AZD7442 are of acceptable quality, safety and efficacy. This is an independent process and approval can only be determined when the full data has been provided by the manufacturer.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 15/11/2021 13:44:16 answering member 4447 label Biography information for Maggie Throup
tabling member	3912 label Biography information for Richard Fuller

720220

registered interest
date	13/04/2017
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Zero Hours Contracts
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, how many people aged between 16 and 24-years old are employed on zero-hours contracts in (a) Jarrow constituency, (b) South Tyneside, (c) the North East and (d) the UK.
tabling member constituency	Jarrow
tabling member printed	Mr Stephen Hepburn
uin	70252
answer	answer is ministerial correction date of answer 25/04/2017 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 25/04/2017 14:23:17 question first ministerially corrected 25/04/2017 16:20:54 answering member 4021 label Biography information for Chris Skidmore attachment 1 file name PQ70251, 70252 v.02 (1).pdf title UKSA Response to PQ70251 and PQ70252 previous answer version 45931 answering member constituency Kingswood answering member printed Chris Skidmore answering member 4021 label Biography information for Chris Skidmore
tabling member	520 label Biography information for Mr Stephen Hepburn